Novanta Completes Acquisition of Riverpoint Medical
June 9, 2026
Novanta has completed its acquisition of Riverpoint Medical from Arlington Capital Partners for an upfront cash consideration of $1.2 billion plus a $250 million milestone payment. The deal expands Novanta’s portfolio into high-growth minimally invasive surgical consumables and is expected to double Novanta’s recurring medical consumables revenue to roughly $300 million.
- Buyers
- Novanta Inc., Arlington Capital Partners
- Targets
- Riverpoint Medical
- Sellers
- Arlington Capital Partners
- Industry
- Healthcare Services
- Location
- Oregon, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.